SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-039486
Filing Date
2023-06-23
Accepted
2023-06-23 17:41:27
Documents
1
Period of Report
2023-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4043
  Complete submission text file 0001209191-23-039486.txt   5558
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Issuer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Al-Wakeel Yasir B. (Reporting) CIK: 0001650691 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40674 | Film No.: 231038900